This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Clinical trial NCT03754660 · COMPLETED
Trial details
- NCT number
- NCT03754660
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2022-04-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.